Skip to main content

Annaida Technologies

Annaida Technologies has developed EmbryoSpin, a micro-Magnetic Resonance Spectroscopy device that enables non-invasive analysis of cellular metabolism in embryos and stem-cell organoids. This technology enhances embryo selection in assisted reproductive therapy and improves research efficiency in toxicology and drug discovery by providing precise metabolic profiling.

Traction 7/10
Lausanne, Switzerland · HQ
Founded 2018101K+ followers
  • Biotechnology
  • Hardware
Updated 23 months ago

Funding

Raised to date

$1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Marco Grisi

CEO

Product

Problem

Current methods for analyzing cellular metabolism in embryos and stem-cell organoids often involve invasive procedures or toxic additives, compromising the integrity of the sample. Traditional techniques also lack the sensitivity to characterize the metabolic fingerprint of microscopic life accurately and efficiently.

Solution

Annaida Technologies offers EmbryoSpin, a micro-Magnetic Resonance Spectroscopy (micro-MRS) device that enables non-invasive analysis of cellular metabolism in microscopic biological samples. The device leverages magnetic resonance spectroscopy to characterize the metabolic fingerprint of delicate 3D biological samples without the need for contrast agents or invasive procedures. EmbryoSpin allows researchers to analyze samples ranging from 50 microns to 1 millimeter in size, such as microtissues, embryos, and organoids. The device yields a complete reading of the chemistry inside biological samples, eliminating the need for multiple cumbersome techniques. It can be used as an add-on to an existing or newly purchased magnet.

Target Audience

The primary users are researchers in toxicology, drug discovery, and life science labs, as well as ART (Assisted Reproductive Therapy) professionals in fertility clinics.

Features

  • Non-invasive micro-MRS technology for metabolic analysis
  • Label-free analysis, eliminating the need for toxic additives or contrast agents
  • Characterization of 3D biological samples, including microtissues, embryos, and organoids
  • Detection and quantification of compounds found in microscopic life
  • Compact magnetic resonance sensor with a microchip at its heart
  • Seamless integration into existing workflows
This profile is AI-generated and may contain inaccuracies.